IHS Chemical Week

World News and Views :: Top of the News

Mallinckrodt to acquire Cadence Pharmaceuticals

2:09 AM MST | February 13, 2014 | Natasha Alperowicz

Mallinckrodt, a specialty pharmaceutical and medical imaging group, says that it has entered into a definitive agreement to acquire all outstanding shares of Cadence Pharmaceuticals for $14.00/share in cash, or approximately $1.3 billion. Subject to terms and conditions, the parties expect the transaction to close in mid- to late March. Mallinckrodt says it expects the acquisition to be immediately accretive to its fiscal 2014 adjusted diluted earnings per share and significantly accretive to its fiscal 2015 adjusted diluted earnings per share.   Cadence is...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa